Analysts See $-0.03 EPS for Corindus Vascular Robotics, Inc. (CVRS)

March 14, 2018 - By Kenneth Lin

 Analysts See $ 0.03 EPS for Corindus Vascular Robotics, Inc. (CVRS)

Analysts expect Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) to report $-0.03 EPS on March, 21.They anticipate $0.05 EPS change or 62.50 % from last quarter’s $-0.08 EPS. After having $-0.04 EPS previously, Corindus Vascular Robotics, Inc.’s analysts see -25.00 % EPS growth. The stock increased 14.67% or $0.1995 during the last trading session, reaching $1.5595. About 2.23 million shares traded or 201.59% up from the average. Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) has risen 8.65% since March 14, 2017 and is uptrending. It has underperformed by 8.05% the S&P500.

Corindus Vascular Robotics, Inc. designs, makes, and sells robotic-assisted precision vascular intervention systems for use in interventional vascular procedures. The company has market cap of $294.28 million. The firm offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures. It currently has negative earnings. The Company’s CorPath system facilitates stent positioning for PCI procedures by allowing a physician to measure, manipulate, and advance devices with robotic precision; and CorPath GRX system enables the precise, robotic-assisted control of coronary guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit.

More important recent Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) news were published by: which released: “Corindus Vascular Robotics (CVRS) Reports FDA Clearance for CorPath GRX System …” on February 20, 2018, also published article titled: “Corindus Vascular Robotics (CVRS) Announces FDA Clearance for First Automated …”, published: “Corindus Vascular Robotics (CVRS) Says Delray Beach Medical Center Performs …” on February 22, 2018. More interesting news about Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) was released by: and their article: “Corindus: You Might Want To Sit Down For This” with publication date: October 19, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: